Endocare rejects acquisition bid
This article was originally published in The Gray Sheet
Executive Summary
Cryocare prostate cancer cryoablation device developer Endocare rejects HealthTronics' unsolicited acquisition proposal, the company announces Aug. 13. HealthTronics, a urology service provider and device distributor, offered to pay $2.28 per share Aug. 6, but Endocare's board unanimously agreed the offer is inadequate (1"The Gray Sheet" Aug. 11, 2008, In Brief)